Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Dec 02, 2022

SELL
$4.08 - $5.82 $844 - $1,204
-207 Reduced 1.74%
11,715 $64,000
Q2 2022

Oct 03, 2022

SELL
$4.15 - $8.37 $1,933 - $3,900
-466 Reduced 3.76%
11,922 $54,000
Q1 2022

Jun 08, 2022

SELL
$5.91 - $14.38 $981 - $2,387
-166 Reduced 1.32%
12,388 $91,000
Q4 2021

Mar 17, 2022

BUY
$5.21 - $8.61 $65,406 - $108,089
12,554 New
12,554 $81,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $54.3M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track American Trust Portfolio

Follow American Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Trust, based on Form 13F filings with the SEC.

News

Stay updated on American Trust with notifications on news.